0
Article |

Postmortem Changes in Brain Catecholamine Enzymes

Ira B. Black, MD; Susan C. Geen
[+] Author Affiliations

Accepted for publication Aug 1, 1974.

Reprint requests to Department of Neurology, Cornell University Medical College, 1300 York Ave, New York, NY 10021 (Dr. Black).


Arch Neurol. 1975;32(1):47-49. doi:10.1001/archneur.1975.00490430069012
Text Size: A A A
Published online

Postmortem changes in the activities of tyrosine hydroxylase, dopa decarboxylase, and dopamine-β-hydroxylase were examined in various areas of rat brain. Tyrosine hydroxylase activity decreased in an exponential fashion with a half-time of two to four hours in caudate-putamen, substantia nigra, and locus ceruleus. Dopa decarboxylase activity remained within 20% of control values at five hours in these areas, but then decreased precipitously. Dopamine-β-hydroxylase activity remained within 20% of control for at least 20 hours after death.

REFERENCES

McDowell F, Barbeau A (eds): Advances in Neurology. Second Canadian-American Conference on Parkinson's Disease, New York, Raven Press, 1974, vol 5.
Kety SS:  Biochemical theories of schizophrenia . Science 129:1528-1532, 1959;.
Wise DC, Stein L:  Dopamine-β-hydroxylase deficits in the brains of schizophrenic patients . Science 181:344-347, 1973;.
Snyder SH, Banerjee SP, Yamamura HI, et al:  Drugs, neurotransmitters and schizophrenia . Science 184:1243-1253, 1974;.
Perry TL, Berry K, Hansen S, et al:  Regional distribution of amino acids in human brain obtained at autopsy . J Neurochem 18:513-519, 1971;.
Lloyd KG, Hornykiewicz O:  Occurrence and distribution of aromatic L-amino acid (L-DOPA) decarboxylase in the human brain . J Neurochem 19:1549-1559, 1972;.
Levitt M, Spector S, Sjoerdsma A, et al:  Elucidation of the rate-limiting step in norepinephrine biosynthesis in the perfused guinea pig heart . J Pharmacol Exp Ther 148:1-8, 1965;.
Lovenberg W, Weissbach H, Udenfriend S:  Aromatic L-amino acid decarboxylase . J Biol Chem 237:89-93, 1962;.
Bogdanski DF, Weissbach H, Udenfriend S:  The distribution of serotonin, 5-hydroxy-tryptophan decarboxylase, and monoamine oxidase in brain . J Neurochem 1:272-278, 1957;.
Kuntzman R, Shore PA, Bogdanski D, et al:  Microanalytical procedures for fluorometric assay of brain DOPA-5 HTP decarboxylase, nor-epinephrine and serotonin, and a detailed mapping of decarboxylase activity in brain . J Neurochem 6:226-232, 1961;.
McCaman RE, McCaman MW, Hunt JM, et al:  Microdetermination of monoamine oxidase and 5-hydroxytryptophan decarboxylase activities in nervous tissues . J Neurochem 12:15-23, 1965;.
Black IB, Hendry IA, Iversen LL:  Differences in the regulation of tyrosine hydroxylase and DOPA decarboxylase in sympathetic ganglia and adrenal . Nature 231:27-29, 1971;.
Kaufman S, Friedman S:  Dopamine-β-hydroxylase . Pharmacol Rev 17:71-100, 1965;.
Goldstein M:  Part 2 , in Peisach A, Aisen L, Blumberg C (eds): The Biochemistry of Copper . New York, Academic Press, 1966;, p 443.
Reis DJ, Molinoff PB:  Brain dopamine-βhydroxylase: Regional distribution and effects of lesions and 6-hydroxydopamine on activity . J Neurochem 19:195-204, 1972;.
Dahlström A, Fuxe K:  Evidence for the existence of monoamine-containing neurons in the central nervous system: I. Demonstration of monoamines in the cell bodies of brainstem neurons . Acta Physiol Scand 62( (suppl 232) ):1-55, 1964;.
Anden N-E, Dahlström A, Fuxe K, et al:  Ascending monoamine neurons to the telencephalon and diencephalon . Acta Physiol Scand 67:313-326, 1966;.
Black IB, Reis DJ:  Ontogeny of the induction of tyrosine hydroxylase by reserpine in the superior cervical ganglion, nucleus locus coeruleus and adrenal gland . Brain Res , to be published.
König JRR, Klippel RA: The Rat Brain: A Stereotaxic Atlas . Milwaukee, Wis, Robert E. Krieger Publishing Co Inc, 1970;.
Hendry IA, Iversen LL:  Effect of nerve growth factor and its antiserum on tyrosine hydroxylase activity in mouse superior cervical ganglion . Brain Res 29:159-162, 1971;.
Black IB, Geen SC:  Trans-synaptic regulation of adrenergic neuron development: Inhibition by ganglionic blockade . Brain Res 63:291-302, 1973;.
Lamprecht F, Coyle JT:  DOPA decarboxylase in the developing rat brain . Brain Res 41:503-506, 1972;.
Joh T, Ross RA, Reis DJ:  A simple and sensitive method for dopamine-β-hydroxylase assay . Anal Biochem , to be published.

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

McDowell F, Barbeau A (eds): Advances in Neurology. Second Canadian-American Conference on Parkinson's Disease, New York, Raven Press, 1974, vol 5.
Kety SS:  Biochemical theories of schizophrenia . Science 129:1528-1532, 1959;.
Wise DC, Stein L:  Dopamine-β-hydroxylase deficits in the brains of schizophrenic patients . Science 181:344-347, 1973;.
Snyder SH, Banerjee SP, Yamamura HI, et al:  Drugs, neurotransmitters and schizophrenia . Science 184:1243-1253, 1974;.
Perry TL, Berry K, Hansen S, et al:  Regional distribution of amino acids in human brain obtained at autopsy . J Neurochem 18:513-519, 1971;.
Lloyd KG, Hornykiewicz O:  Occurrence and distribution of aromatic L-amino acid (L-DOPA) decarboxylase in the human brain . J Neurochem 19:1549-1559, 1972;.
Levitt M, Spector S, Sjoerdsma A, et al:  Elucidation of the rate-limiting step in norepinephrine biosynthesis in the perfused guinea pig heart . J Pharmacol Exp Ther 148:1-8, 1965;.
Lovenberg W, Weissbach H, Udenfriend S:  Aromatic L-amino acid decarboxylase . J Biol Chem 237:89-93, 1962;.
Bogdanski DF, Weissbach H, Udenfriend S:  The distribution of serotonin, 5-hydroxy-tryptophan decarboxylase, and monoamine oxidase in brain . J Neurochem 1:272-278, 1957;.
Kuntzman R, Shore PA, Bogdanski D, et al:  Microanalytical procedures for fluorometric assay of brain DOPA-5 HTP decarboxylase, nor-epinephrine and serotonin, and a detailed mapping of decarboxylase activity in brain . J Neurochem 6:226-232, 1961;.
McCaman RE, McCaman MW, Hunt JM, et al:  Microdetermination of monoamine oxidase and 5-hydroxytryptophan decarboxylase activities in nervous tissues . J Neurochem 12:15-23, 1965;.
Black IB, Hendry IA, Iversen LL:  Differences in the regulation of tyrosine hydroxylase and DOPA decarboxylase in sympathetic ganglia and adrenal . Nature 231:27-29, 1971;.
Kaufman S, Friedman S:  Dopamine-β-hydroxylase . Pharmacol Rev 17:71-100, 1965;.
Goldstein M:  Part 2 , in Peisach A, Aisen L, Blumberg C (eds): The Biochemistry of Copper . New York, Academic Press, 1966;, p 443.
Reis DJ, Molinoff PB:  Brain dopamine-βhydroxylase: Regional distribution and effects of lesions and 6-hydroxydopamine on activity . J Neurochem 19:195-204, 1972;.
Dahlström A, Fuxe K:  Evidence for the existence of monoamine-containing neurons in the central nervous system: I. Demonstration of monoamines in the cell bodies of brainstem neurons . Acta Physiol Scand 62( (suppl 232) ):1-55, 1964;.
Anden N-E, Dahlström A, Fuxe K, et al:  Ascending monoamine neurons to the telencephalon and diencephalon . Acta Physiol Scand 67:313-326, 1966;.
Black IB, Reis DJ:  Ontogeny of the induction of tyrosine hydroxylase by reserpine in the superior cervical ganglion, nucleus locus coeruleus and adrenal gland . Brain Res , to be published.
König JRR, Klippel RA: The Rat Brain: A Stereotaxic Atlas . Milwaukee, Wis, Robert E. Krieger Publishing Co Inc, 1970;.
Hendry IA, Iversen LL:  Effect of nerve growth factor and its antiserum on tyrosine hydroxylase activity in mouse superior cervical ganglion . Brain Res 29:159-162, 1971;.
Black IB, Geen SC:  Trans-synaptic regulation of adrenergic neuron development: Inhibition by ganglionic blockade . Brain Res 63:291-302, 1973;.
Lamprecht F, Coyle JT:  DOPA decarboxylase in the developing rat brain . Brain Res 41:503-506, 1972;.
Joh T, Ross RA, Reis DJ:  A simple and sensitive method for dopamine-β-hydroxylase assay . Anal Biochem , to be published.

Correspondence

CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.